查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599301

虚拟临床试验市场：依研究设计，相关 - 全球预测 2025-2030

Virtual Clinical Trials Market by Study Design (Expanded Access Trials, Interventional Trials, Observational Trials), Implication (Cardiovascular Disease, Oncology) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年虚拟临床试验市场价值为38.1亿美元，预计到2024年将达到46.6亿美元，复合年增长率为22.44%，到2030年将达到157.2亿美元。

虚拟临床试验 (VCT) 是临床研究的一种创新方法，它透过支援远端参与和资料收集的数位工具和平台来补充或取代临床试验的传统方面。 VCT 的需求源于增加参与者多样性、降低成本以及提高病患可及性和依从性的需要。它特别适用于药物和治疗方法开发的各个阶段，其中以患者为中心的资料收集至关重要。主要最终用户包括希望简化业务并覆盖更广泛受众的製药公司、生物技术公司和受託研究机构。

主要市场统计
基准年[2023] 38.1亿美元
预测年份 [2024] 46.6亿美元
预测年份 [2030] 157.2亿美元
复合年增长率（%） 22.44%

根据市场洞察，数位健康创新的激增和远距远端医疗接受度的提高正在显着影响成长。穿戴式科技、人工智慧和机器学习的进步使 VCT 更有效率和个人化，为在临床试验中进一步整合真实世界证据提供了机会。企业正在透过投资先进的资料管理解决方案并确保遵守不断变化的监管标准来利用这些进步。然而，也存在可能阻碍广泛使用的限制，例如资料隐私问题、技术偏见和国际法规的差异。此外，一些地区基础设施不发达，人口差异造成的数位落差也是一大问题。

业务成长的创新领域包括开发用于分散临床试验的安全平台、增强数位患者招募策略以及利用区块链确保资料安全。关于人工智慧在预测分析和病患监测中的作用的研究也很有前景。市场动态的特点是技术快速进步，需要灵活的策略和伙伴关係来有效渗透市场。企业应专注于与高科技公司建立合作，以推动产品创新，并与监管机构合作，塑造有利于 VCT 的环境。总体而言，利用以患者为中心的创新，同时解决隐私和监管挑战，对于虚拟临床试验的持续成长和成功至关重要。

市场动态：揭示快速发展的虚拟临床试验市场的关键市场洞察

虚拟临床试验市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大远端医疗的采用
    • 医疗领域更采用数位化世界
    • 活性化研发活动并结合政府的有利支持
  • 市场限制因素
    • 对大规模资料采集、资料准确性和可靠性以及技术故障的担忧
  • 市场机会
    • 将新技术融入临床试验
    • 在软体、生物技术和临床研究公司之间建立合作
  • 市场问题
    • 与受试者註册和参与活动相关的复杂且困难的过程

波特五力：驾驭虚拟临床试验市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解虚拟临床试验市场的外部影响

外部宏观环境因素在塑造虚拟临床试验市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过检查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解虚拟临床试验市场的竞争格局

虚拟临床试验市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：虚拟临床试验市场供应商的绩效评估

FPNV 定位矩阵是评估虚拟临床试验市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製虚拟临床试验市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对虚拟临床试验市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章 关键测试方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 远端医疗的采用率增加
      • 在医疗领域，数位化的采用正在全球扩大
      • 研发活动迅速增加和政府的有利支持
    • 抑制因素
      • 对大规模资料采集、资料准确性和可靠性以及技术故障的担忧
    • 机会
      • 将新技术融入临床试验
      • 软体、生物技术和临床研究试验公司之间的新合作
    • 任务
      • 与註册和参与活动相关的繁琐且困难的流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 虚拟临床试验市场：依研究设计

  • 介绍
  • 扩大访问考试
  • 干预试验
  • 观察测试

第七章 虚拟临床试验市场：依相关性

  • 介绍
  • 心血管疾病
  • 瘤

第八章美洲虚拟临床试验市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太虚拟临床试验市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的虚拟临床试验市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AiCure, LLC
  • Clinical Ink, Inc. by GI Partners
  • CliniOps, Inc
  • Everest Global, Inc
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Medidata Solutions by Dassault Systemes SE
  • Medpace, Inc.
  • MedPoint Digital, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Pfizer Inc.
  • VirTrial, LLC by Signant Health
Product Code: MRR-A339DAEFA4E6

The Virtual Clinical Trials Market was valued at USD 3.81 billion in 2023, expected to reach USD 4.66 billion in 2024, and is projected to grow at a CAGR of 22.44%, to USD 15.72 billion by 2030.

Virtual clinical trials (VCTs) are innovative approaches in clinical research where the traditional aspects of trial conduction are complemented or replaced by digital tools and platforms, enabling remote participation and data collection. The necessity for VCTs arises from the need to enhance participant diversity, reduce costs, and improve patient accessibility and compliance, especially pertinent during global events like pandemics where physical distancing is vital. They find application in numerous phases of drug and therapy development, particularly where patient-centric data collection is paramount. Key end-users include pharmaceutical companies, biotechnology firms, and contract research organizations aiming to streamline operations and reach broader demographics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.81 billion
Estimated Year [2024] USD 4.66 billion
Forecast Year [2030] USD 15.72 billion
CAGR (%) 22.44%

Market insights reveal a surge in digital health innovations and an increasing acceptance of telemedicine, significantly influencing growth. Factors such as advancements in wearable technology, AI, and machine learning are driving efficiencies and personalization in VCTs, opening up opportunities for further integration of real-world evidence in research. Companies are capitalizing on these advancements by investing in sophisticated data management solutions and ensuring compliance with evolving regulatory standards. However, limitations include data privacy concerns, technological biases, and varying international regulations that could hinder widespread adoption. The lack of infrastructure in certain regions and the digital divide between different demographic groups pose significant challenges.

For business growth, areas of innovation include development of secure platforms for decentralized trials, enhancement of digital patient recruitment strategies, and leveraging blockchain for data security. Research into AI's role in predictive analytics and patient monitoring is also promising. Market dynamics are characterized by rapid technological advancements, which necessitate agile strategies and partnerships for effective market penetration. Companies should focus on forging collaborations with tech firms to drive product innovation, and engage with regulatory bodies to shape favorable landscapes for VCTs. Overall, tapping into patient-centric innovations while addressing privacy and regulatory challenges will be crucial for the sustained growth and success of virtual clinical trials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virtual Clinical Trials Market

The Virtual Clinical Trials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of telehealth
    • Growing adoption of digitization in healthcare sector globally
    • Proliferation in research and development activities coupled with favorable government support
  • Market Restraints
    • Concerns over large data collection, data accuracy and reliability, and technological failure
  • Market Opportunities
    • Integration of new technologies in clinical trials
    • Emerging collaborations between software, biotechnology and clinical research companies
  • Market Challenges
    • Cumbersome and difficult process with enrolment and engagement activities

Porter's Five Forces: A Strategic Tool for Navigating the Virtual Clinical Trials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virtual Clinical Trials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virtual Clinical Trials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virtual Clinical Trials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virtual Clinical Trials Market

A detailed market share analysis in the Virtual Clinical Trials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virtual Clinical Trials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virtual Clinical Trials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virtual Clinical Trials Market

A strategic analysis of the Virtual Clinical Trials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virtual Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Clinical Ink, Inc. by GI Partners, CliniOps, Inc, Everest Global, Inc, ICON PLC, IQVIA Inc., Medable, Inc., Medidata Solutions by Dassault Systemes S.E., Medpace, Inc., MedPoint Digital, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Pfizer Inc., and VirTrial, LLC by Signant Health.

Market Segmentation & Coverage

This research report categorizes the Virtual Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Study Design, market is studied across Expanded Access Trials, Interventional Trials, and Observational Trials.
  • Based on Implication, market is studied across Cardiovascular Disease and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of telehealth
      • 5.1.1.2. Growing adoption of digitization in healthcare sector globally
      • 5.1.1.3. Proliferation in research and development activities coupled with favorable government support
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of new technologies in clinical trials
      • 5.1.3.2. Emerging collaborations between software, biotechnology and clinical research companies
    • 5.1.4. Challenges
      • 5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Virtual Clinical Trials Market, by Study Design

  • 6.1. Introduction
  • 6.2. Expanded Access Trials
  • 6.3. Interventional Trials
  • 6.4. Observational Trials

7. Virtual Clinical Trials Market, by Implication

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Oncology

8. Americas Virtual Clinical Trials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Virtual Clinical Trials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Virtual Clinical Trials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AiCure, LLC
  • 2. Clinical Ink, Inc. by GI Partners
  • 3. CliniOps, Inc
  • 4. Everest Global, Inc
  • 5. ICON PLC
  • 6. IQVIA Inc.
  • 7. Medable, Inc.
  • 8. Medidata Solutions by Dassault Systemes S.E.
  • 9. Medpace, Inc.
  • 10. MedPoint Digital, Inc.
  • 11. Navitas Inc.
  • 12. Oracle Corporation
  • 13. Parexel International Corporation
  • 14. Pfizer Inc.
  • 15. VirTrial, LLC by Signant Health

LIST OF FIGURES

  • FIGURE 1. VIRTUAL CLINICAL TRIALS MARKET RESEARCH PROCESS
  • FIGURE 2. VIRTUAL CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRTUAL CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRTUAL CLINICAL TRIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023